BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Treatment
334 results:

  • 1. Evolving insights into the improvement of adoptive T-cell immunotherapy through PD-1/PD-L1 blockade in the clinical spectrum of lung cancer.
    Li Y; Sharma A; Schmidt-Wolf IGH
    Mol Cancer; 2024 Apr; 23(1):80. PubMed ID: 38659003
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice.
    van Kooten JP; Dietz MV; Dubbink HJ; Verhoef C; Aerts JGJV; Madsen EVE; von der Thüsen JH
    Clin Exp Med; 2024 Apr; 24(1):80. PubMed ID: 38642130
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Association of the Advanced lung cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer.
    Jiang H; Li B; Wu M; Wang Q; Li Y
    BMC Cancer; 2024 Apr; 24(1):428. PubMed ID: 38589844
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Outcome differences by sex in oncology clinical trials.
    Kammula AV; Schäffer AA; Rajagopal PS; Kurzrock R; Ruppin E
    Nat Commun; 2024 Mar; 15(1):2608. PubMed ID: 38521835
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Canonical DDR activation by EMT inducing agent 5-Fluorouracil is modulated by a cannabinoid based combinatorial approach via inducing autophagy and suppression of vimentin expression.
    Mir KB; Chakraborty S; Amin T; Kumar A; Rouf War A; Nalli Y; Kumar R; Dinesh Kumar L; Ali A; Goswami A
    Biochem Pharmacol; 2024 May; 223():116126. PubMed ID: 38490521
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis.
    Guo H; Lin H
    BMC Surg; 2024 Mar; 24(1):79. PubMed ID: 38438944
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR-TKIs.
    Gu Z; Huang P; Zhao J; Luo C; Liao L; Liu A; Huang L
    Int J Cancer; 2024 Jun; 154(11):1979-1986. PubMed ID: 38353428
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.
    Besse B; Pons-Tostivint E; Park K; Hartl S; Forde PM; Hochmair MJ; Awad MM; Thomas M; Goss G; Wheatley-Price P; Shepherd FA; Florescu M; Cheema P; Chu QSC; Kim SW; Morgensztern D; Johnson ML; Cousin S; Kim DW; Moskovitz MT; Vicente D; Aronson B; Hobson R; Ambrose HJ; Khosla S; Reddy A; Russell DL; Keddar MR; Conway JP; Barrett JC; Dean E; Kumar R; Dressman M; Jewsbury PJ; Iyer S; Barry ST; Cosaert J; Heymach JV
    Nat Med; 2024 Mar; 30(3):716-729. PubMed ID: 38351187
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cinobufotalin effect and mechanism on serum MMP-2, MMP-9, Beclin1, LC3-II in advanced NSCLC patients.
    Yang L; Bai B; Chen H; Li T; Wang M; Zhu X
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(15):58-62. PubMed ID: 38279494
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Large-scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors.
    Li Q; Patrick MT; Sreeskandarajan S; Kang J; Kahlenberg JM; Gudjonsson JE; He Z; Tsoi LC
    Front Immunol; 2023; 14():1309549. PubMed ID: 38259463
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Impact of Pleural Lavage Cytology Positivity on Early Recurrence After Surgery for Non-Small Cell lung cancer.
    Recuero Díaz JL; Gatius Caldero S; Rosado Rodríguez J; Caamaño Villaverde V; Gómez de Antonio D; Tejerina E; Sánchez Moreno L; Martino González M; Moldes Rodríguez M; Abdulkader Nallib I; Ramírez Gil E; Amat Villegas I; Genovés Crespo M; García Ángel R; Sampedro Salinas C; Figueroa Almánzar S; Compañ Quilis A; Saumench Perramon R; González Pont G; Royo Crespo Í; Gambó Grasa P; García Fernández JL; Jiménez Heffernan JA; Cerón Navarro J; Prieto Rodríguez M; Porcel JM
    Arch Bronconeumol; 2024 Mar; 60(3):133-142. PubMed ID: 38238188
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Boosted abscopal effect from radiotherapy and pembrolizumab in anaplastic thyroid cancer: a mini-review and case report.
    Goh D; Lim KH; Sudirman SRB; Ang MK; Chua MLK; Lim CM
    Chin Clin Oncol; 2023 Oct; 12(5):57. PubMed ID: 37964542
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Alveolar Differentiation Drives Resistance to KRAS Inhibition in lung Adenocarcinoma.
    Li Z; Zhuang X; Pan CH; Yan Y; Thummalapalli R; Hallin J; Torborg S; Singhal A; Chang JC; Manchado E; Dow LE; Yaeger R; Christensen JG; Lowe SW; Rudin CM; Joost S; Tammela T
    Cancer Discov; 2024 Feb; 14(2):308-325. PubMed ID: 37931288
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Deep learning based MLC aperture and monitor unit prediction as a warm start for breast VMAT optimisation.
    Vandewinckele L; Reynders T; Weltens C; Maes F; Crijns W
    Phys Med Biol; 2023 Nov; 68(22):. PubMed ID: 37903442
    [No Abstract]    [Full Text] [Related]  

  • 15. Screening, Diagnosis, and Initial Care of Asian and White Patients With lung cancer.
    Hu X; Melson JW; Pan SS; Salei YV; Cao Y
    Oncologist; 2024 Apr; 29(4):332-341. PubMed ID: 37797084
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors.
    Cui B; Song L; Wang Q; Li K; He Q; Wu X; Gao F; Liu M; An C; Gao Q; Hu C; Hao X; Dong F; Zhou J; Liu D; Song Z; Yan X; Zhang J; Bai Y; Mao Q; Yang X; Liang Z
    Signal Transduct Target Ther; 2023 Sep; 8(1):366. PubMed ID: 37743418
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Polo‑like kinase 1 selective inhibitor BI2536 (dihydropteridinone) disrupts centrosome homeostasis via atm‑ERK cascade in adrenocortical carcinoma.
    Lin RC; Chao YY; Lien WC; Chang HC; Tsai SW; Wang CY
    Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37477142
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Somatic and germline atm variants in non-small-cell lung cancer: Therapeutic implications.
    Hernandez-Martinez JM; Rosell R; Arrieta O
    Crit Rev Oncol Hematol; 2023 Aug; 188():104058. PubMed ID: 37343657
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of FKBP10 prognostic value in lung adenocarcinoma patients with surgical resection of brain metastases: A retrospective single-institution cohort study.
    Liu ZD; Wang SQ; Li S; He J; Wang SH; Cai HQ; Wan JH
    Clinics (Sao Paulo); 2023; 78():100212. PubMed ID: 37201304
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Development and validation of prognostic nomogram for malignant pleural mesothelioma].
    Xie XJ; Chen JY; Jiang J; Duan H; Wu Y; Zhang XW; Yang SJ; Zhao W; Shen SS; Wu L; He B; Ding YY; Luo H; Liu SY; Han D
    Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):415-423. PubMed ID: 37188627
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 17.